Material - End Use Products: Data Requirements for Use Site Category (USC # 18)
Material - End Use Products
Data Code | Title | Data required | Conditions | Volume No and Pages |
---|---|---|---|---|
0 | Index | R | ||
1 | Label | R | ||
3 | Chemistry Requirements for the Registration of Manufacturing Concentrates and End-Use Products Formulated from Registered technical grade of active ingredients or integrated system products | |||
3.1 | Product Identification | |||
3.1.1 | Applicant's Name and Office Address | R | ||
3.1.2 | Formulating Plant's Name and Address | R | ||
3.1.3 | Trade Name | R | ||
3.1.4 | Other Names | R | ||
3.2 | Formulation Process | |||
3.2.1 | Description of Starting Materials | R | ||
3.2.2 | Description of the Formulation Process | R | ||
3.2.3 | Discussion of the Formation of Impurities of Toxicological Concern | CR | If applicable | |
3.3 | Specifications | |||
3.3.1 | Establishing Certified Limits | R | ||
3.3.2 | Control Product Specification Form | R | ||
3.4 | Product Analysis | |||
3.4.1 | Enforcement Analytical Method | R | ||
3.4.2 | Impurities of Toxicological Concern | CR | If applicable | |
3.5 | Chemical and Physical Properties | |||
3.5.1 | Colour | CR | Required for manufacturing concentrates only | |
3.5.2 | Physical State | R | ||
3.5.3 | Odour | CR | Required for manufacturing concentrates only | |
3.5.4 | Formulation Type | R | ||
3.5.5 | Container Material and Description | R | ||
3.5.6 | Density or Specific Gravity | R | ||
3.5.7 | pH | R | ||
3.5.8 | Oxidizing or Reducing Action (Chemical Incompatibility) | R | ||
3.5.9 | Viscosity | R | ||
3.5.10 | Storage Stability Data | R | ||
3.5.11 | Flammability | R | ||
3.5.12 | Explodability | R | ||
3.5.13 | Miscibility | R | ||
3.5.14 | Corrosion Characteristics | R | ||
3.5.15 | Dielectric Breakdown Voltage | R | ||
3.6 | Sample(s) | CR | If requested by PMRA | |
3.7 | Other Studies/Data/Reports | CR | If available | |
4 | Toxicology | |||
4.1 | Summaries | R | ||
4.6 | Acute Studies - EP | |||
4.6.1 | Acute Oral | R | ||
4.6.2 | Acute Dermal | R | ||
4.6.3 | Acute Inhalation | R | ||
4.6.4 | Primary Eye Irritation | R | ||
4.6.5 | Primary Dermal Irritation | R | ||
4.6.6 | Dermal Sensitization | R | ||
4.6.7 | Potentiation/Interaction | CR | If available | |
4.6.8 | Other Acute Studies | CR | If available | |
4.7 | Short-term Studies - EP | CR | Depending on use pattern, required if any component of the EP may increase absorption of the active ingredient(s) or increase toxic or pharmacologic effects | |
4.7.1 | Short-term Oral (90-day rodent) | CR | See 4.7 | |
4.7.2 | Short-term Oral (90-day and/or 12-month dog) | CR | See 4.7 | |
4.7.3 | Short-term Dermal (90-day) | CR | See 4.7 | |
4.7.4 | Short-term Dermal (21/28-day) | CR | See 4.7 | |
4.7.5 | Short-term Inhalation (21/28-day) | CR | See 4.7 | |
4.7.6 | Short-term Inhalation (90-day) | CR | See 4.7 | |
4.7.7 | Other Special Studies | CR | See 4.7 | |
4.8 | Other Studies/Data/Reports | CR | If available | |
5 | Exposure (Occupational and/or Bystander) | |||
5.1 | Summaries | R | ||
5.2 | Use Description/Scenario (Application and Post Application) | R | ||
5.3 | Pesticides Handlers Exposure Database Assessment (or other database) | R | One of 5.3, 5.4 or 5.5 is required | |
5.4 | Mixer/Loader/Applicator- Passive Dosimetry Data | R | See 5.3 | |
5.5 | Mixer/Loader/Applicator-Biological Monitoring Data | R | See 5.3 | |
5.6 | Post Application - Passive Dosimetry Data | CR | Only one of 5.6 or 5.7 is required when there is a potential for post-application exposure | |
5.7 | Post Application - Biological monitoring Data | CR | See 5.6 | |
5.8 | Dermal Absorption | CR | May be required if the margin of safety is inadequate | |
5.11 | Glove/Clothing Penetration Data | CR | May be required for risk mitigation purposes or for inadequate margin of safety | |
5.13 | Package Integrity Study | CR | Required if packaged in water soluble bags | |
5.14 | Other Studies/Data/Reports | CR | If available | |
8 | Environmental Chemistry and Fate | |||
8.1 | Summaries | R | ||
8.2 | Laboratory Studies | |||
8.2.3 | Laboratory Studies of Transformation | |||
8.2.3.1 | Summary | R | ||
8.2.3.6 | Special Studies Related to Use-Pattern or Formulation | CR | ||
8.2.4 | Laboratory Studies of Mobility | |||
8.2.4.1 | Summary | CR | ||
8.2.4.6 | Special Studies Related to Use-Pattern or Formulation | CR | ||
8.3 | Field Studies of Dissipation/ Accumulation [May be Small- or Large-Scale] | |||
8.3.1 | Summary | CR | ||
8.3.2 | Terrestrial | |||
8.3.2.1 | Canada | CR | ||
8.3.2.2 | Northern U.S. | CR | Can substitute for Canadian studies, if they are required | |
8.3.3 | Aquatic | |||
8.3.3.1 | Canada | CR | Based on potential for aquatic exposure and if pesticide residues have the potential for persistence, mobility, non-target aquatic toxicity or bioaccumulation | |
8.3.3.2 | Northern U.S. | CR | See 8.3.2.2 | |
8.3.4 | Special Studies Related to Intended Use Pattern | CR | Based on concerns arising from results of other studies | |
8.4 | Storage, Disposal and Decontamination (TGAI and EP) | |||
8.4.1 | Summary | R | ||
8.5 | Other Environmental Fate Studies (TGAI and EP) | |||
8.5.1 | Summary | CR | Based on concerns arising from results of other studies | |
8.6 | Other Studies/Data/Reports | CR | If available | |
9 | Environmental Toxicology | |||
9.1 | Summary | CR | ||
9.3 | Non-Target Freshwater Invertebrates | |||
9.3.1 | Summary | CR | If there is a potential for freshwater exposure | |
9.3.5 | Laboratory Studies | CR | If components of the EP are of concern | |
9.3.6 | Field Studies | CR | Based on concerns arising from results of other studies | |
9.4 | Non-Target Marine Invertebrates | |||
9.4.1 | Summary | CR | If there is a potential for estuarine/marine exposure |
|
9.4.6 | Laboratory Studies | CR | If there is a potential for exposure and components of the EP are of concern | |
9.4.7 | Field Studies | CR | Based on concerns arising from results of other studies | |
9.5 | Fish | |||
9.5.1 | Summaries | CR | If there is a potential for exposure | |
9.5.4 | Laboratory Studies | CR | If components of the EP are of concern | |
9.5.5 | Field Studies | CR | Based on concerns arising from results of other studies | |
9.7 | Wild Mammals | |||
9.7.1 | Summary | CR | Based on concerns arising from results of other studies | |
9.7.2 | Field Studies | CR | See 9.7.1 | |
9.8 | Non-Target Plants | |||
9.8.1 | Summary | CR | ||
9.8.6 | Laboratory Studies | CR | If components of the EP are of concern | |
9.8.7 | Field Studies | CR | Based on concerns arising from results of other studies | |
9.9 | Other Studies/Data/Reports | CR | If available | |
10 | Value (applicable to each pest/site or host combination) | |||
10.1 | Value Summaries | CR | Will become required when companies have been informed; Overall summary of Part 10; Includes registration status and/or labels from other countries | |
10.2 | Efficacy Studies | |||
10.2.1 | Mode of Action | R | Statement that mode of action is unknown is acceptable | |
10.2.2 | Description of Pest Problem | |||
Identity of Pest | R | |||
Benefits/Need for Control of Pest | CR | Required if a new site-pest combination | ||
Any Biological Aspect of Pest That Affect Application Rates/Timing | CR | Required if a new site-pest combination | ||
10.2.3 | Efficacy Trials | |||
10.2.3.1 | Summaries | CR | Will become required when companies have been informed; Includes any requests for waivers | |
10.2.3.2 | Laboratory Trials (includes minimal effective dose) including test protocol(s) | R | Or an operational trial see 10.2.3.4 Requirement to be determined at preliminary review | |
10.2.3.3 | Small-scale Trials including test protocol(s) | CR | Required for products to be used in fuel; May be required for products used in drilling muds, mine tailings, leather, metal cutting fluid and miscellaneous sites depending on variation of site and/or substrate. Not required for products used in textiles, paint, canvas, caulking, carpet, mattresses and upholstered furniture | |
10.2.3.4 | Operational Trials | CR | Large scale, often unreplicated operation use trials for which a research permit is usually required. Requirement to be determined at preliminary review. | |
10.3 | Adverse Effects on Use Site | |||
10.3.1 | Summaries | CR | ||
10.3.2 | Non-Safety Adverse Effects | R | Statement that there are no known adverse effects if acceptable; Includes discolouration, corrosion, deposits, etc. | |
10.4 | Economics | CR | Requirement determined at preliminary review | |
10.5 | Sustainability | |||
10.5.1 | Survey of Alternatives | CR | Requirement determined at preliminary review; Includes chemical or non-chemical alternatives | |
10.5.2 | Compatibility with Current Management Practices Including IPM | CR | Requirement determined at preliminary review | |
10.5.3 | Resistance Management | CR | Requirement determined at preliminary review | |
10.5.4 | Contribution to Risk Reduction | CR | Requirement determined at preliminary review | |
10.6 | Other Studies/Data/Reports | CR | If available | |
12.5 | Foreign Reviews | |||
12.5.3 | Foreign Reviews of Chemistry Requirements for MAs and EPs formulated from registered TGAIs or ISPs | CR | ||
12.5.4 | Foreign Reviews of Toxicology | CR | ||
12.5.5 | Foreign Reviews of Exposure - Occupational and/or Bystander |
CR | ||
12.5.8 | Foreign Reviews of Environmental Chemistry and Fate | CR | ||
12.5.9 | Foreign Reviews of Environmental Toxicology | CR | ||
12.5.10 | Foreign Reviews of Value | CR | ||
12.7 | Comprehensive Data Summaries | R |
Page details
- Date modified: